Description:
A large 27-nation clinical trial shows that postmenopausal women with estrogen-receptor-positive breast cancer are less likely to get new breast cancers -- especially cancers in distant parts of the body -- if they take Femara than if they take tamoxifen
Hits:
147 |
Rating:
( 5.0 )
by 1 users
Added:
9/20/2004